Herbas VPB

Print
EN | LT
LT - Stabilios antikūnų kompozicijos prieš žmogaus programuojamos mirties receptorių PD-1 ir susiję gydymo būdai
EN - STABLE FORMULATIONS OF ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 AND RELATED TREATMENTS

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 31/00 (2006.01)
A61K 39/395 (2006.01)
A61K 9/19 (2006.01)
A61K 9/00 (2006.01)
A61K 47/18 (2017.01)
A61K 47/26 (2006.01)
A61P 31/12 (2006.01)
A61P 35/00 (2006.01)
C07K 16/28 (2006.01)
A61K 39/00 (2006.01)
European patent
(11) Number of the document 2691112
(13) Kind of document T
(96) European patent application number 12763896.3
Date of filing the European patent application 2012-03-29
(97) Date of publication of the European application 2014-02-05
(45) Date of publication and mention of the grant of the patent 2018-05-23
(46) Date of publication of the claims translation 2018-07-25
PCT application
(86) Number PCT/US2012/031063
Date 2012-03-29
PCT application publication
(87) Number WO 2012/135408
Date 2012-10-04
Priority applications
(30) Number Date Country code
201161470121 P 2011-03-31 US
Inventors
(72)
SHARMA, Manoj K., US
NARASIMHAN, Chakravarthy Nachu, US
GERGICH, Kevin James, US
KANG, Soonmo Peter, US
Grantee
(73) Merck Sharp & Dohme Corp., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Stabilios antikūnų kompozicijos prieš žmogaus programuojamos mirties receptorių PD-1 ir susiję gydymo būdai
  STABLE FORMULATIONS OF ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1 AND RELATED TREATMENTS
Last renewal fee
Payment date Validity (years) Amount
2025-02-10 14 289.00 EUR
Next renewal fee
2026-03-29